IRCT201109113307N5已完成2 期
Comparing the Efficacy and Safety of Hepatitis B vaccine of Pasteur Institute of Iran and Cuban Heber biotec Company’s in Iranian healthy volunteers
Pasteur Institute of Iran (IPI)0 个研究点目标入组 440 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Healthy volunteers
- •completed inform consent
- •Exclusion criteria:
- •HBsAg+ or HBcAb+ patients
- •Previous incubation of hepatitis B vaccine or serum HBsAb >10 mIU/ml before the first dose of vaccine incubation
- •Patients with: Thalassemia, any malignancies, Immunodeficiency, HIV, DM, Liver failure and dialysis patients
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A study to determine the optimum timing of Hepatitis B vaccination during treatment of Acute Lymphoblastic leukemia( a type of blood cancer)CTRI/2017/08/009402JIPMER58
已完成
不适用
Comparison of effectiveness of hepatitis B revaccination schemes in healthy non-respondershepatitis B vaccine non-response10047438NL-OMON41474eids Universitair Medisch Centrum480
进行中（未招募）
1 期
Comparison of 4 different Hepatitis B vaccines in healthy persons in whom a standard hepatitis B vaccination schedule of three vaccinations did not induces a protective immune response, so-called non-responders.EUCTR2011-005627-40-NL480
招募中
不适用
The effect of Hepatitis B preventive education on knowledge and attitude of Afghan students.Hepatitis B prevention education.Acute hepatitis BIRCT20180611040055N1Iran University of Medical Sciences140
已完成
不适用
The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously Resolved HBV Infection Receiving Immunosuppressive Therapy to Prevent HBV Reactivation through Increase of Serum Levels of Anti-HBs (Pilot Study)Collagen disease, collagen disease related disease, ulcerative colitis, Crohn's disease, intestinal Behcet's disease (simple ulcers included), psoriasis, and diseases that require other immunosuppressive therapies.JPRN-UMIN000042288Saitama Medical University13